The venoms of all mamba species are known to contain potent neurotoxins. Some authors suggest that cardiotoxins from mamba venom are responsible for heart failure in envenomated patients. This study was undertaken to come to a better understanding of the mechanisms and possible effects of mamba venom on the hearts of animals. The venoms of three mamba species namely Dendroaspis polylepis, Dendroaspis angusticeps, and Dendroaspis jamesoni were screened for cardiotoxicity by the cardiomyocyte viability test on cardiomyocytes isolated enzymatically from guinea pig ventricle muscle. This analysis was followed by an electrophysiological evaluation of the effects of venoms (from the Dendroaspis species) on cardiac ion channels by employing the whole-cell clamp procedure. In this study the cardiomyocyte viability test indicates differences among the venoms of the three mamba species. The venom of D. jamesoni seems to be the most potent followed by D. angusticeps and then D. polylepis. The whole-cell clamp results indicate that the venoms have no affinity for cardiac potassium channels but have an inhibitory influence on cardiac L-calcium channels. Although this study provides evidence that mamba venoms have a specific effect on isolated myocytes of guinea pig, it is doubtful that it will have a profound influence on a human heart in case of envenomation.

Download full-text PDF

Source
http://dx.doi.org/10.1580/1080-6032(1996)007[0115:pcotvo]2.3.co;2DOI Listing

Publication Analysis

Top Keywords

mamba species
16
venoms three
12
three mamba
12
mamba venom
8
cardiomyocyte viability
8
viability test
8
guinea pig
8
whole-cell clamp
8
venoms
7
mamba
7

Similar Publications

Snakes responsible for bites are rarely identified, resulting in a loss of information about snakebites from venomous species whose venom effects are poorly understood. A prospective clinical study including patients bitten by a snake was conducted in Cameroon between 2019 and 2021 to evaluate the efficacy and tolerability of a marketed polyvalent antivenom. Clinical presentation during the first 3 days of hospitalization was recorded following a standardized protocol.

View Article and Find Full Text PDF

Recent research suggests that a polygeneric immunogen made from the venoms of the most medically important viperid and elapid snakes in sub-Saharan Africa could elicit a broader antibody response in horses compared to the current EchiTAb-plus-ICP antivenom, especially against neurotoxic elapid venoms. To test this, 25 horses that have been regularly immunized to produce this antivenom were reimmunized with an immunogen containing 22 venoms from various snake species from the genera , , , and both spitting and non-spitting . The plasma collected from these horses was processed using the caprylic acid method to produce an industrial-scale freeze-dried antivenom.

View Article and Find Full Text PDF

In the face of rapidly accumulating genomic data, our ability to accurately predict key mature RNA properties that underlie transcript function and regulation remains limited. Pre-trained genomic foundation models offer an avenue to adapt learned RNA representations to biological prediction tasks. However, existing genomic foundation models are trained using strategies borrowed from textual or visual domains that do not leverage biological domain knowledge.

View Article and Find Full Text PDF
Article Synopsis
  • * Producing oligoclonal antibodies in a single batch is more cost-effective than making multiple individual monoclonal antibody batches, making the manufacturing process more efficient.
  • * The study successfully created a stable oligoclonal antibody mixture targeting toxins from various elapid snake venoms, demonstrating a viable strategy for producing tailored antivenoms for snakebites and potentially other medical applications.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!